The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis-Reference-Cited by-同舟云学术

The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis

Published:2021-10-03 Issue: Volume: Page:
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Safipour Zohreh,van der Zanden Rogier^ORCID,van den Bergh Joop^ORCID,Janssen Paddy^ORCID,Vestergaard Peter,de Vries Frank^ORCID,Driessen Johanna H. M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s00198-021-06101-3.pdf

Reference30 articles.

1. Yeh J-H, Chen H-J, Chen Y-K, Chiu H-C, Kao C-H (2014) Increased risk of osteoporosis in patients with myasthenia gravis: a population-based cohort study. Neurology 83(12):1075–1079. https://doi.org/10.1212/WNL.0000000000000804

2. Farmakidis C, Pasnoor M, Dimachkie MM, Barohn RJ (2018) Treatment of myasthenia gravis. Neurol Clin 36(2):311–337. https://doi.org/10.1016/j.ncl.2018.01.011

3. Vestergaard P, Olsen ML, Paaske Johnsen S, Rejnmark L, Sørensen HT, Mosekilde L (2003) Corticosteroid use and risk of hip fracture: a population-based case-control study in Denmark. J Intern Med 254(5):486–493. https://doi.org/10.1046/j.1365-2796.2003.01219.x

4. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15(6):993–1000. https://doi.org/10.1359/jbmr.2000.15.6.993

5. Vestergaard P, Rejnmark L, Mosekilde L (2005) Fracture risk associated with systemic and topical corticosteroids. J Intern Med 257(4):374–384. https://doi.org/10.1111/j.1365-2796.2005.01467.x

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Bone Density Changes and Fracture Risk in Myasthenia Gravis: Implications for FRAX® Tool Application;Healthcare;2024-09-08

2. The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis;Osteoporosis International;2024-05-15

3. Ten-year fracture risk in Japanese patients with myasthenia gravis: A comprehensive assessment using the fracture risk assessment tool;Journal of the Neurological Sciences;2024-05

4. Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data;PLOS ONE;2023-03-01